부산대학교 도서관

Feld, L.; Hellmers, S.; Schell-Majoor, L.; Koschate-Storm, J.; Zieschang, T.; Hein, A.; Kollmeier, B.

IEEE Open Journal of Engineering in Medicine and Biology IEEE Open J. Eng. Med. Biol. Engineering in Medicine and Biology, IEEE Open Journal of. 6:570-575 2025

Heitmann, Jonas S, MD; Maringer, Yacine, PhD; Jung, Susanne, MD; Wacker, Marcel, MSc; Hackenbruch, Christopher, MD; Polster, Mark, MSc; Marconato, Maddalena, MD; Nelde, Annika, PhD; Bauer, Jens, PhD; Zwick, Melissa, PhD; Baur, Anna-Sophia, MSc; Metzger, Ariane, MSc; Krolla, Christopher, MSc; Andrieux, Geoffroy, PhD; Köhler, Natalie, Prof; Boerries, Melanie, Prof; Denk, Monika, PhD; Zieschang, Lisa; Kammer, Christine; Hoenisch-Gravel, Naomi, MSc; Richter, Marion, PhD; Oezbek, Melek Tutku, MSc; Wirths, Stefan, MD; Dengler, Anna, MSc; Dubbelaar, Marissa L, PhD; Pumptow, Marina, PhD; Martus, Peter, Prof; Brüggemann, Monika, Prof; Rammensee, Hans-Georg, Prof; Salih, Helmut R, Prof; Walz, Juliane S, Prof

The Lancet Haematology. 13(2):e74-e85

L. P. Beyer; L. von zur Gathen; B. El Rayah; O. Dewald; T. Zieschang; A. Diers; E. Wesley Ely; U. Guenther

BMC Anesthesiology, Vol 24, Iss 1, Pp 1-10 (2024)

Zieschang, Hanna E.; Sievers, Andreas

Planta, 1991 Jan 01. 184(4), 468-477.

C. Hackenbruch; J.S. Heitmann; S. Jung; Y. Maringer; M. Wacker; A. Nelde; M. Marconato; L. Zieschang; C. Kammer; M.T. Özbek; M. Richter; M. Denk; H.R. Salih; J.S. Walz

Annals of Oncology. 35:S601-S602

Jessica Koschate; L. Thieschäfer; U. Drescher; T. Zieschang; U. Hoffmann

Eur J Appl Physiol

R. Diekmann; S. Hellmers; L. Elgert; S. Fudickar; A. Heinks; S. Lau; J. M. Bauer; T. Zieschang; A. Hein

Aging Clin Exp Res

Pickert, L.; Schlotmann, J.; Diesner, N.; Heess, A.; Meyer, A. M.; Nelles, M. C. Polidori; Zieschang, T.; Von Arnim, C.

Nelles, M. C. Polidori; Pickert, L.; Veronese, N.; Topinkova, E.; von Arnim, C.; Zieschang, T.; Verissimo, R. T.; Sanchez, E. M.; Cella, A.; Cenderello, G.; Castagna, A.; Pilotto, A.; Custureri, R.; Dini, S.; Farinella, S. T.; Ruotolo, G.; Padovani, A.; Custodero, C.; Cruz-Jentoft, A.

Jung S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Nelde A; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Maringer Y; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Denk M; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.; Zieschang L; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.; Kammer C; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Özbek M; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.; Martus P; Institute for Clinical Epidemiology and Applied Biometry, University and Faculty of Medicine, University of Tübingen, Tübingen, Germany.; Hackenbruch C; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Englisch A; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.; Heitmann JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Walz JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University of Tübingen and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Englisch A; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Department of Obstetrics and Gynecology, University Hospital Tübingen, Tübingen, Germany.; Hayn C; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Jung S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Heitmann JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Hackenbruch C; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Maringer Y; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Nelde A; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Wacker M; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Denk M; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Zieschang L; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Kammer C; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Martus P; Institute for Clinical Epidemiology and Applied Biometry, University Hospital Tübingen, Tübingen, Germany.; Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Walz JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Fukuyama, H.; Weber, W. L.

The Journal of the Operational Research Society, 2002 Sep 01. 53(9), 992-1003.

Beyer, L. P.; Gathen, L. von zur; Rayah, B. El; Dewald, O.; Zieschang, T.; Diers, A.; Ely, E. Wesley; Guenther, U.

BMC Anesthesiology (BMC ANESTHESIOL), 12/13/2024; 24(1): 1-10. (10p)

Hackenbruch, C.; Bauer, J.; Heitmann, J. S.; Jung, S.; Maringer, Y.; Nelde, A.; Denk, M.; Zieschang, L.; Missios, P.; Bonzheim, I; Ebinger, M.; Salih, H. R.; Bitzer, M.; Walz, J. S.

ONCOLOGY RESEARCH AND TREATMENT; OCT 20 2025, 48 SUPPL 2, 2p. Supplement: 2

K. Büter; T. Motzek; B. Dietz; L. Hofrichter; M. Junge; D. Kopf; H. von Lützau-Hohlbein; S. Traxler; T. Zieschang; G. Marquardt

Zeitschrift für Gerontologie und Geriatrie. 50:67-72

Hackenbruch C; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Bauer J; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Heitmann JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Maringer Y; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Nelde A; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Denk M; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Zieschang L; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Kammer C; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Federmann B; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Jung S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Martus P; Institute for Medical Biometrics and Clinical Epidemiology, University Hospital Tübingen, Tübingen, Germany.; Malek NP; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.; Center for Personalized Medicine, University of Tübingen, Tübingen, Germany.; The M3 Research Institute, University of Tübingen, Tübingen, Germany.; Nikolaou K; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany.; Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Bitzer M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.; Center for Personalized Medicine, University of Tübingen, Tübingen, Germany.; Walz JS; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Yi Ju; Christina Cortez‐Jugo; Jingqu Chen; Ting‐Yi Wang; Andrew J. Mitchell; Evelyn Tsantikos; Nadja Bertleff‐Zieschang; Yu‐Wei Lin; Jiaying Song; Yizhe Cheng; Srinivas Mettu; Md. Arifur Rahim; Shuaijun Pan; Gyeongwon Yun; Margaret L. Hibbs; Leslie Y. Yeo; Christoph E. Hagemeyer; Frank Caruso

Advanced Science, Vol 7, Iss 6, Pp n/a-n/a (2020)

Klenk, J.; Chiari, L.; Helbostad, J. L.; Zijlstra, W.; Aminian, K.; Todd, C.; Bandinelli, S.; Kerse, N.; Schwickert, L.; Mellone, S.; Bagalá, F.; Delbaere, K.; Hauer, K.; Redmond, S. J.; Robinovitch, S.; Aziz, O.; Schwenk, M.; Zecevic, A.; Zieschang, T.; Becker, C.

Zeitschrift fur Gerontologie und Geriatrie. 46(8):720-726

J. Hummel; C. Weisbrod; L. Bösch; K. Himpler; G. Böhm; S. Diener; A. Gaebel; L. Dipper; T. Zieschang; P. Oster; D. Kopf

Zeitschrift für Gerontologie und Geriatrie. 45:34-39

Gonçalves, Daciberg L.; Kudryavtseva, Elena; Zieschang, Heiner

manuscripta mathematica. 107:311-341